The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...
March 10, 2010 (UPDATED March 17, 2010) — The US Food and Drug Administration (FDA) has approved a new indication for onabotulinumtoxin A injection (Botox; Allergan, Inc) for upper limb spasticity.
The upper limb exhibits a remarkable degree of anatomical variation in muscle morphology, impacting both clinical management and surgical approaches. Variations such as ectopic insertions and ...
Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the ...
-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...
A recent clinical trial has shown that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy. A ...
Victoria University provides funding as a member of The Conversation AU. Cyclists in this year’s Tour de France – currently underway – will cover more than 3,300km over 21 stages in 23 days. Of course ...
To date, muscle function, and in particular that of the lower extremity, in OI type IV has not been investigated systematically. This study now assesses upper and lower extremity muscle function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results